Skip to content

pharmaceuticals.co.nz

Drugs, medicines and medical news
Main navigation

R1 Therapeutics launches with $77.5m to advance hyperphosphatemia treatment

R1 Therapeutics launches with .5m to advance hyperphosphatemia treatment
p p Read More

Financing and global licensing deal to accelerate phase 2b development of AP306

March 17, 2026 News

Taiwan Bio partners with Terumo to advance automated Treg manufacturing

Taiwan Bio partners with Terumo to advance automated Treg manufacturing
p p Read More

Collaboration aims to streamline and scale next‑generation Treg therapy production

March 17, 2026 News

Measles: children and vulnerable communities face disproportionate harms

The recent measles outbreaks across the UK, US, and Europe are more than a series of vaccination failures. […]

March 17, 2026 Uncategorized

DOCUSATE SODIUM (docusate sodium 100mg) capsule [Pharbest Pharmaceuticals, Inc.]

Updated Date: Mon, 09 Mar 2026 00:00:00 EDT

March 17, 2026 Uncategorized

GOJO RICH PINK ANTIBACTERIAL LTN SP (chloroxylenol) liquid [GOJO Industries, Inc.]

Updated Date: Mon, 09 Mar 2026 00:00:00 EDT

March 17, 2026 Uncategorized

Scientists inject one tumor and watch cancer vanish across the body

A redesigned cancer immunotherapy is showing striking early results after decades of disappointment with similar drugs. Researchers engineered […]

March 17, 2026 Uncategorized

Meningitis in Kent: Two young people dead and 11 seriously ill in outbreak

Two young people have died and 11 others are seriously ill in hospital after an outbreak of invasive […]

March 17, 2026 Infectious diseases, Paediatrics, Neurology

Breastfeeding and codeine guidance in doubt after calls for retraction of pivotal Lancet study

A pivotal Lancet case report suggesting that codeine given to breastfeeding mothers could trigger opioid overdoses in babies […]

March 17, 2026 Paediatrics

Elevara begins phase 2b trial of ELV001 in rheumatoid arthritis

Elevara begins phase 2b trial of ELV001 in rheumatoid arthritis
p p Read More

Study to assess oral therapy for patients with inadequate response to TNF inhibitors

March 16, 2026 News

Lebrikizumab shows strong results for children with atopic dermatitis

Lebrikizumab shows strong results for children with atopic dermatitis
p p Read More

Phase 3 trial delivers significant skin clearance and symptom improvement

March 16, 2026 News

Posts navigation

« Previous

Posts pagination

1 2 … 1,965 Next »
Proudly powered by WordPress | Theme: Hive Lite by Pixelgrade.
Footer navigation
  • Privacy Policy